E88.811
Insulin resistance syndrome, Type A
Clinical Classification Guidelines
Medical Intelligence & Overview
Insulin resistance syndrome, Type A, also known as insulin resistance syndrome, is a metabolic condition where the body's cells become less responsive to insulin. Insulin is a hormone that helps regulate blood sugar levels by facilitating the entry of glucose into cells for energy or storage. In this condition, despite the presence of insulin, the body's cells do not respond effectively, leading to increased blood sugar levels and, potentially, the development of type 2 diabetes and other metabolic issues. Accurate diagnosis and management are crucial for preventing long-term health complications related to this syndrome.
Causes & Symptoms
Clinical Causes: Genetic predisposition Obesity, particularly excess abdominal fat Sedentary lifestyle and physical inactivity Unhealthy diet rich in processed foods, sugars, and unhealthy fats Hormonal disorders, such as polycystic ovary syndrome (PCOS) Certain medications that impair insulin sensitivity Chronic stress and inadequate sleep Age and metabolic aging processes
Key Symptoms: Typically asymptomatic in early stages Increased hunger and craving for sugary foods Fatigue and low energy levels Difficulty losing weight despite diet and exercise New or worsening high blood sugar levels High blood pressure Elevated triglycerides and low HDL cholesterol Acanthosis nigricans – darkened patches of skin, usually on the neck or underarms Possible signs of metabolic syndrome such as abdominal obesity
Diagnostic & Treatment
Diagnosis Path: Diagnosis of insulin resistance syndrome, Type A, involves a combination of clinical assessment and laboratory tests. Healthcare providers may evaluate patient history, physical signs, and perform blood tests such as fasting insulin and glucose levels, and oral glucose tolerance tests. The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) is a common calculation used to estimate insulin resistance. Presence of associated metabolic abnormalities, such as high triglycerides, low HDL cholesterol, or hypertension, further supports the diagnosis. No single test definitively confirms insulin resistance, so diagnosis typically relies on a comprehensive evaluation.
Treatment Protocols: Management of insulin resistance syndrome focuses on lifestyle modifications aimed at improving insulin sensitivity and reducing associated risks. Key components include:
Clinical Advice & FAQs
Billing Guidance
Is E88.811 a billable ICD-10 code?
Yes, E88.811 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E88.811?
Clinical documentation must specify the nature of Insulin resistance syndrome, Type A and any associated comorbidities for accurate reporting.
Cite this Clinical Reference